Oppenheimer & Co. Inc. Has $25.36 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Oppenheimer & Co. Inc. lowered its position in shares of The Procter & Gamble Company (NYSE:PG) by 2.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 146,418 shares of the company’s stock after selling 3,705 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Procter & Gamble were worth $25,360,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. International Assets Investment Management LLC boosted its stake in Procter & Gamble by 19,030.8% in the third quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock valued at $639,730,000 after buying an additional 3,674,286 shares in the last quarter. Wulff Hansen & CO. increased its holdings in Procter & Gamble by 16,292.0% in the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock worth $606,230,000 after purchasing an additional 3,653,477 shares in the last quarter. AMF Tjanstepension AB increased its holdings in Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares in the last quarter. Swedbank AB acquired a new stake in Procter & Gamble in the first quarter valued at approximately $233,788,000. Finally, Ilex Capital Partners UK LLP acquired a new stake in Procter & Gamble in the first quarter valued at approximately $228,212,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE PG traded up $0.26 during trading on Wednesday, reaching $166.10. 414,176 shares of the company traded hands, compared to its average volume of 6,635,822. The firm has a 50 day simple moving average of $170.79 and a 200-day simple moving average of $168.29. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $391.17 billion, a PE ratio of 28.59, a P/E/G ratio of 3.59 and a beta of 0.42. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.83 EPS. Equities research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.42%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Transactions at Procter & Gamble

In other news, CEO Jon R. Moeller sold 31,797 shares of the stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $5,380,688.34. Following the transaction, the chief executive officer now owns 300,777 shares in the company, valued at $50,897,483.94. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jon R. Moeller sold 31,797 shares of the stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the sale, the chief executive officer now directly owns 300,777 shares of the company’s stock, valued at approximately $50,897,483.94. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 313,597 shares of company stock worth $53,268,499 in the last quarter. Company insiders own 0.18% of the company’s stock.

Wall Street Analysts Forecast Growth

PG has been the topic of several analyst reports. JPMorgan Chase & Co. lifted their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley boosted their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $177.00.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.